Northrop Grumman NOC Q1 2026 Earnings Defense Contractor Beats EPS Estimates Amid Steady Demand MercedesBenz Signals Openness to Military Sector as Automotive Pressure Mounts GRRR Q4 2025 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Undisclosed XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles Oil Prices Rise as Trump Issues Fresh Warning to Iran European Markets Dip BCRX Q1 2026 Earnings Significant EPS Miss Amid Ongoing Operational Adjustments Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues